RESUMEN
BACKGROUND: A typical non-neoplastic connective tissue proliferations called a pyogenic granuloma. A vascular adhesion molecule used to assess angiogenesis is the CD34 marker. The primary memberof a family of growth factors, VEGF helps in generating and maintaining the lymphatic and blood circulation systems. OBJECTIVE: The aim of the study was to know the correlation between VEGF and CD34 protein marker and pyogenic granuloma. METHODS: Thirty-one formalin fixed paraffin embedded (FFPE) blocks were taken from female pyogenic granuloma patients ranging in age from 29 to 70. The IHC was used to identify VEGF and CD34 expression in the cytoplasm of the cells. RESULTS: Seventeenout of 31 patients had VEGF positive expression. Twenty-sixout of 31 had CD34 positive expression and 5 with no expression (negative expression). Brown-stained cytoplasm showed high VEGF and CD34 expression, whereas blue stained cytoplasm showed no VEGF and CD34 expression in these cells. CONCLUSIONS: The results suggest the role of suchbiomarkers in the oral pyogenic granuloma pathogenesis, and it appears that CD34 and VEGF are valuable biomarkers in evaluating vascular and inflammatory diseases like pyogenic granuloma.
Asunto(s)
Granuloma Piogénico , Humanos , Femenino , Granuloma Piogénico/diagnóstico , Granuloma Piogénico/etiología , Granuloma Piogénico/metabolismo , Factor A de Crecimiento Endotelial Vascular , Molécula 1 de Adhesión Celular Vascular , Neovascularización Patológica/complicaciones , Neovascularización Patológica/metabolismo , Neovascularización Patológica/patología , Antígenos CD34RESUMEN
PURPOSE: To evaluate immunophenotypic profiles of infiltrating cells in surgically excised tissues of chalazion and pyogenic granuloma associated with chalazion. METHODS: Eighty-two surgical specimens from 74 consecutive patients newly diagnosed with chalazion or chalazion-associated pyogenic granuloma at Tokyo Medical University Hospital between 2016 and 2022 were studied. Sixty specimens were chalazion lesions and 22 specimens were pyogenic granuloma lesions (from 15 men and 7 women, mean age 36.6 ± 14.4 years). All patients were immunocompetent Asian Japanese adults. Specimens were analyzed by immunohistochemistry and flow cytometry. Flow cytometry was performed using the following antibodies: CD3, CD4, CD8, CD11b, CD11c, CD16, CD19, CD20, CD23, CD25, CD34, CD44, CD56, CD69, and CD138. RESULTS: In flow cytometric analysis, the proportion of cells expressing the T cell marker CD3 was significantly higher compared with other immune cells expressing specific markers (p < 0.0001), and the proportion of CD4-positive T cells was significantly higher than that of CD8-positive T cells (p < 0.0001), in both chalazion and pyogenic granuloma specimens. The chalazion and pyogenic granuloma lesions shared similar immunophenotypic profile characterized by predominant T cell infiltration, and CD4 T cells dominating over CD8 cells. The pattern of expression of CD4 and CD8 in the specimens was confirmed by immunohistochemistry. CONCLUSION: The present study demonstrates immunophenotypic features of chalazion and chalazion-associated pyogenic granuloma. Although various inflammatory cells are involved in the pathology of chalazion and pyogenic granuloma, a significantly higher proportion of CD4-positive T cells may be closely related to the pathological mechanisms of both lesions.
Asunto(s)
Chalazión , Granuloma Piogénico , Masculino , Adulto , Humanos , Femenino , Adulto Joven , Persona de Mediana Edad , Chalazión/metabolismo , Granuloma Piogénico/diagnóstico , Granuloma Piogénico/metabolismo , Granuloma Piogénico/patología , Inmunofenotipificación , Linfocitos T CD4-Positivos/metabolismo , Linfocitos T CD4-Positivos/patología , Linfocitos T CD8-positivos/metabolismo , Linfocitos T CD8-positivos/patología , Citometría de FlujoRESUMEN
BACKGROUND: Pyogenic granuloma (PG) is a lesion characterized by the proliferation of blood vessels, commonly affecting the skin and the mouth. We aimed to compare clinical, microscopic, and immunohistochemical features of the two types of oral PG: lobular capillary hemangioma (LCH) and non-LCH (NLCH). METHODS: Epidemiological and clinical data from 2000 to 2018 were collected from the archives of our institution, and histopathological sections of PG were reviewed. Immunohistochemical analyses (CD34, D2-40, SMA, mast cell, and Ki-67) were performed in 34 cases. RESULTS: Sixty-two LCH and 107 non-LCH samples were included. The mean (±SD) age of the patients was 38.59 ± 16.96 years; 55.62% were female; 39.64% of cases occurred in the gingiva, 44% of the nodules were pedunculated, and 13.02% of patients reported a history of trauma. NLCH was more prevalent among older patients than LCH. The most prevalent site of LCH was the lips, while NLCH occurred more in the gingiva (P < 0.05). Epithelial atrophy, microvessels, SMA-positive areas, and Ki-67-positive nuclei were more prevalent in LCH (P < 0.05). CONCLUSIONS: PG accounted for 2.25% of lesions archived in the pathology service and most cases were NLCH. LCH and NLCH exhibited clinicopathological differences in terms of age, site, epithelial atrophy, vascularization, and proliferation rate.
Asunto(s)
Granuloma Piogénico/diagnóstico , Granuloma Piogénico/metabolismo , Mucosa Bucal/patología , Neovascularización Patológica/patología , Actinas/metabolismo , Adulto , Biopsia , Estudios de Casos y Controles , Femenino , Encía/patología , Granuloma Piogénico/epidemiología , Granuloma Piogénico/patología , Humanos , Inmunohistoquímica/métodos , Antígeno Ki-67/metabolismo , Labio/patología , Masculino , Persona de Mediana Edad , Boca/patología , Mucosa Bucal/irrigación sanguínea , Mucosa Bucal/ultraestructura , Prevalencia , Estudios RetrospectivosRESUMEN
In the last 30 years, there has been a strong interest in vascular proliferations. Pyogenic granuloma was not only renamed lobular capillary hemangioma, but also the conceptual interpretation was also changed from an overgrowth of granulation tissue to a genuine hemangioma (or benign vascular neoplasm). We describe 19 cases of patients who presented clinically with a vascular lesion, characteristically a pyogenic granuloma or lobular hemangioma, where the histopathological findings led to the pathologic concern for a lymphoma of the skin. These benign lesions with a dense lymphoid infiltrate were further defined on the basis of different vascular and lymphoid immunohistochemical markers as inflammatory lobular hemangiomas. We propose that given the considerable histopathological overlap between acral pseudolymphomatous angiokeratoma, T-cell rich angiomatoid polypoid pseudolymphoma of the skin, and other designations of some of these vascular proliferations with a rich and dense lymphoid infiltrate, they might constitute a spectrum of vascular lesions with varying clinical presentations.
Asunto(s)
Proliferación Celular , Granuloma Piogénico , Hemangioma , Neoplasias Cutáneas , Linfocitos T , Adolescente , Adulto , Anciano , Niño , Femenino , Granuloma Piogénico/metabolismo , Granuloma Piogénico/patología , Hemangioma/irrigación sanguínea , Hemangioma/metabolismo , Hemangioma/patología , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Cutáneas/irrigación sanguínea , Neoplasias Cutáneas/metabolismo , Neoplasias Cutáneas/patología , Linfocitos T/metabolismo , Linfocitos T/patologíaRESUMEN
The angiogenesis inhibitor ramucirumab (IMC-1121B) is a fully humanised IgG1 monoclonal antibody targeting the extracellular domain of vascular endothelial growth factor receptor 2. Ramucirumab has been approved as a second-line treatment for lung cancer. Pyogenic granuloma is an acquired, benign vascular tumour of the skin or mucous membrane. We encountered a patient with pyogenic granuloma who was treated with ramucirumab. The patient was a 48-year-old Japanese woman with advanced lung cancer who had been heavily pretreated using several lines of chemotherapy. Ramucirumab was administered as the fifth-line treatment with docetaxel. After 10 days, a painless rice-coloured or pink papule appeared on her finger. One month later, it increased in size to 20 mm. We examined the pathological condition by immunostaining using the resected specimen diagnosed as pyogenic granuloma. Paradoxically, this vascular tumour arose during the administration of an angiogenesis inhibitor.
Asunto(s)
Anticuerpos Monoclonales Humanizados/efectos adversos , Antineoplásicos/efectos adversos , Granuloma Piogénico/etiología , Granuloma Piogénico/metabolismo , Receptor 2 de Factores de Crecimiento Endotelial Vascular/biosíntesis , Anticuerpos Monoclonales Humanizados/uso terapéutico , Antineoplásicos/uso terapéutico , Femenino , Humanos , Persona de Mediana Edad , RamucirumabRESUMEN
BACKGROUND: Pyogenic granuloma (PG) is a benign nodular lesion with a prominent vascular component which may affect different sites. Recently, BRAF, KRAS, HRAS, NRAS, GNA11, and GNA14 mutations were reported on PGs of the skin. The present study assessed the role of the MAPK/ERK pathway in oral PG pathogenesis. METHODS: Mutations in hotspot regions of genes involved in the MAPK/ERK pathway activation were investigated by Sanger sequencing. The expression of phospho-ERK1/2 was evaluated by immunohistochemistry. RESULTS: Oral PGs did not show mutations in the sequenced regions of the genes BRAF, KRAS, HRAS, NRAS, GNA11, or GNA14. Our results also showed activation of the MAPK/ERK pathway demonstrated by phospho-ERK1/2 immunohistochemical positivity. CONCLUSIONS: Although oral PG shows MAPK/ERK pathway activation, the driver molecular event remains to be elucidated.
Asunto(s)
Granuloma Piogénico/metabolismo , Sistema de Señalización de MAP Quinasas , Mutación , Adolescente , Adulto , Anciano , Femenino , GTP Fosfohidrolasas/metabolismo , Subunidades alfa de la Proteína de Unión al GTP/metabolismo , Subunidades alfa de la Proteína de Unión al GTP Gq-G11/metabolismo , Granuloma Piogénico/genética , Humanos , Masculino , Proteínas de la Membrana/metabolismo , Persona de Mediana Edad , Proteínas Proto-Oncogénicas B-raf/metabolismo , Proteínas Proto-Oncogénicas p21(ras)/metabolismo , Transducción de Señal , Adulto JovenRESUMEN
Congenital cutaneous pyogenic granuloma is a rare benign vascular tumor with clinical and histopathological features similar to infantile hemangioma. It usually presents as a red, pedunculated and highly friable papule. On histopathological analysis, one can see a capillary vessel proliferation with lobular pattern and endothelial proliferation. The differential diagnosis is based on negativity of glucose transporter 1 (GLUT1) immunochemistry studies. We report two infants with congenital pyogenic granuloma, one with a unique cutaneous lesion and the other with multiple lesions affecting both skin and mucosal surfaces. These two cases highlight the importance of the differential diagnosis based on the GLUT1 immunochemistry analysis considering the distinct treatments required to these infant vascular tumors.
Asunto(s)
Transportador de Glucosa de Tipo 1/metabolismo , Granuloma Piogénico , Proteínas de Neoplasias/metabolismo , Neoplasias Vasculares , Diagnóstico Diferencial , Femenino , Granuloma Piogénico/congénito , Granuloma Piogénico/diagnóstico , Granuloma Piogénico/metabolismo , Granuloma Piogénico/patología , Humanos , Lactante , Recién Nacido , Masculino , Neoplasias Vasculares/congénito , Neoplasias Vasculares/diagnóstico , Neoplasias Vasculares/metabolismo , Neoplasias Vasculares/patologíaRESUMEN
AIMS: To systematically describe the clinical and histopathological features of a case series of conjunctival carcinomatous lesions underlying as-and also masquerading-pyogenic granuloma. METHODS: Nine cases of conjunctival carcinomatous lesions underlying a pyogenic granuloma (which were clinically predominant) were retrospectively identified. Patients' records were analysed for demographic data, clinical appearance and the postoperative course. Formalin-fixed paraffin-embedded specimens were routinely processed and stained with H&E and periodic acid-Schiff. Immunohistochemical stains for cytokeratin were performed in selected cases. RESULTS: All nine tumours were located in the conjunctiva (bulbar, tarsal, limbal conjunctiva) of patients between 44 and 80 years. The lesions exhibited clinical features of pyogenic granuloma which dominated the clinical appearance. Additional features comprised a papillomatous appearance of the adjacent conjunctiva, a more whitish aspect of the lesion and a history of squamous cell carcinoma (SCC) respectively surgery for other entities. Histopathological analysis revealed a carcinomatous lesion (conjunctival intraepithelial neoplasia or SCC) at the base of a classic pyogenic granuloma in all nine cases. Surgical removal (R0 resection) was performed. Three cases received adjuvant mitomycin C or interferon α2b treatment. Two lesions locally recurred within 2 years after initial presentation. CONCLUSION: Carcinomatous lesions may be accompanied by a pyogenic granuloma which may dominate the clinical pictures. As the tumour is usually located at the base of the lesion, a complete surgical excision followed by histopathological analysis is mandatory for each lesion appearing as conjunctival pyogenic granuloma.
Asunto(s)
Carcinoma in Situ/diagnóstico , Carcinoma de Células Escamosas/diagnóstico , Neoplasias de la Conjuntiva/diagnóstico , Granuloma Piogénico/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Antineoplásicos/uso terapéutico , Biomarcadores de Tumor/metabolismo , Carcinoma in Situ/metabolismo , Carcinoma in Situ/cirugía , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/cirugía , Quimioterapia Adyuvante , Neoplasias de la Conjuntiva/metabolismo , Neoplasias de la Conjuntiva/cirugía , Diagnóstico Diferencial , Femenino , Granuloma Piogénico/metabolismo , Granuloma Piogénico/cirugía , Humanos , Interferón alfa-2 , Queratinas/metabolismo , Masculino , Persona de Mediana Edad , Mitomicina/uso terapéutico , Estudios RetrospectivosRESUMEN
A 52-year-old man presented with a rapidly growing red tumor on the central neckline. It had appeared over a congenital flat and pinkish vascular lesion that involved the shoulder and the upper anterior area of his chest. Intermingled with the pinkish stain, there were also some blue nodules several millimeters in diameter. Histopathologic examination revealed that the full lesion was a mixed venous-capillary malformation. The red tumor was excised and diagnosed as a pyogenic granuloma developing over the venous component of the vascular malformation. To our knowledge, a pyogenic granuloma growing over a venous malformation has not been previously described.
Asunto(s)
Granuloma Piogénico/patología , Neoplasias Cutáneas/patología , Malformaciones Vasculares/patología , Granuloma Piogénico/metabolismo , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Cutáneas/metabolismo , Malformaciones Vasculares/metabolismoRESUMEN
Pyogenic granuloma (PG) is a type of vascular tumor for which the growth mechanism is poorly understood. Estrogen and progesterone may influence vascular malformations by increasing neovascularization in the lesions. Pregnancy tumor is a term for PG that occurs on the gingival mucosa of pregnant women in response to local irritation or injury. The etiology and pathogenesis of this phenomenon are not fully understood. Hormonal imbalance has been hypothesized to be responsible for the development of gingival hyper-reactive inflammatory responses. Moreover, it has been shown in vitro that the female sex hormone is a potential regulator of the production of several growth factors, such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor, and nerve growth factor, in various cell types. Epidermal growth factor receptor (EGFR) is also involved in a signaling cascade that influences proliferation and other tumor-promoting activities, as well as the responsiveness to chemotherapy. The aim of this study was to examine the relationship between PG pathogenesis and hormone imbalance in 21 patients. All specimens were analyzed by immunohistochemical staining with hematoxylin and eosin for the following hormones: estrogen receptor, progesterone receptor, VEGF, and EGFR. The analysis of the specimens showed that estrogen receptor and EGFR were not associated with PG, while VEGF was statistically related to PG. In addition, there was no significantly difference between sex, tumor location, or pregnancy. There are few studies about correlation between the pathogenesis of PG and sex hormones or growth factors demonstrated via immunohistochemical analysis. The results of this study indicate that estrogen and progesterone do not influence the pathogenesis of PG; however, VEGF may be associated with the pathogenesis of PG.
Asunto(s)
Encía , Granuloma Piogénico , Hormonas/análisis , Inmunohistoquímica , Complicaciones del Embarazo , Estudios de Cohortes , Femenino , Encía/química , Encía/metabolismo , Encía/patología , Granuloma Piogénico/metabolismo , Granuloma Piogénico/patología , Humanos , Embarazo , Complicaciones del Embarazo/metabolismo , Complicaciones del Embarazo/patología , Transducción de SeñalRESUMEN
BACKGROUND: Pyogenic granulomas are benign, reactive, typically superficial vascular lesions that can be idiopathic or arise secondary to trauma, underlying vascular malformations, infections, physiologic or pathologic endocrine changes, and hormone therapy. Deep-seated/subcutaneous pyogenic granulomas (DSPG) are rarely seen in any age group. Pediatric DSPGs can be a clinical and pathologic challenge because these lesions mimic other vascular lesions, including kaposiform hemangioendothelioma, infantile hemangiomas and vascular malformations. METHODS: Retrospective search of DSPG excised at Cincinnati Children's Hospital Medical center between June 2010 and June 2011 was conducted. Clinical information was obtained from patient charts and histologic slides were retrieved and reviewed. RESULTS: Of the 106 cases of pyogenic granuloma, 4 (3.8%) were diagnosed as DSPG. We report the details of those 4 cases and compare them with the other pediatric DSPG cases reported in the literature. We also review the histologic differential diagnosis of DSPG in pediatric population. CONCLUSION: Our results suggest that these lesions may not be as rare as inferred by literature, but, rather, underdiagnosed.
Asunto(s)
Granuloma Piogénico , Enfermedades de la Piel , Piel , Adolescente , Niño , Preescolar , Diagnóstico Diferencial , Femenino , Granuloma Piogénico/diagnóstico , Granuloma Piogénico/metabolismo , Granuloma Piogénico/patología , Humanos , Masculino , Piel/metabolismo , Piel/patología , Enfermedades de la Piel/diagnóstico , Enfermedades de la Piel/metabolismo , Enfermedades de la Piel/patologíaRESUMEN
In view of the similarity of clinicopathological features between reactive lesions of the oral cavity, the objective of the present study was to investigate the density of MCs (mast cells) and microvessels in a series of these lesions. Thirty-seven cases of reactive lesions including fibrous hyperplasia (FH, n=10), inflammatory fibrous hyperplasia (IFH, n=10), peripheral giant cell lesion (PGCL, n=10) and lobular capillary hemangioma (LCH, n=7) were investigated using immunohistochemistry for mast cell tryptase and CD34. For comparative purposes, central giant cell lesions (CGCL, n=5) were included. A higher MC density was observed in LCH (37.01), while CGCL exhibited the lowest density (n=8.14). There was a significant difference in MC density when all reactive lesions were compared to CGCL (p=0.001). The largest mean density of microvessels was observed in LCH (n=21.69). The smallest number was observed in CGCL (n=6.24). There was a significant difference in microvessel density when the reactive lesions were compared to CGCL (p=0.003). There was a significant and direct correlation between the density of MCs and microvessels only for IFH (p=0.048) and CGCL (p=0.005). A significant and direct correlation between the mean density of MCs and microvessels was observed when the reactive lesions were analyzed as a whole (p=0.005). Our results suggest that mast cells contribute to the connective tissue framework and angiogenic function, as well as the development, of reactive lesions of the oral cavity, including FH, IFH, LCH and PGCL.
Asunto(s)
Granuloma de Células Gigantes/patología , Granuloma Piogénico/patología , Mastocitos/patología , Microvasos/patología , Enfermedades de la Boca/patología , Boca/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Recuento de Células , Femenino , Granuloma de Células Gigantes/metabolismo , Granuloma Piogénico/metabolismo , Humanos , Hiperplasia/metabolismo , Hiperplasia/patología , Inmunohistoquímica , Masculino , Mastocitos/metabolismo , Microvasos/metabolismo , Persona de Mediana Edad , Boca/metabolismo , Enfermedades de la Boca/metabolismo , Neovascularización Patológica/metabolismo , Neovascularización Patológica/patología , Adulto JovenRESUMEN
BACKGROUND: The aim of this study was to evaluate the population of intact and degranulated MCs in oral inflammatory lesions. METHODS: A cross sectional study of 48 samples, including inflammatory fibrous hyperplasia, pyogenic granulomas, periapical granulomas and radicular cysts, was performed. Samples of normal gingival mucosa were used as controls. The degree of edema and lymphoplasmacytic infiltrate was determined by the analysis of hematoxylin-eosin (HE)-stained sections. To determine the collagen fibers contents and correlate it with the MC count, sections stained with Sirius red and Toluidine blue were used. Immunohistochemistry with an antivascular endothelial growth factor (VEGF) was also used to count endothelial cells. RESULTS: Although the total number of intact MCs was higher in the oral inflammatory lesions, these differences were not statistically significant (P=0.33). There were statistically significant differences between the numbers of degranulated MCs from the lesions and those from the normal oral mucosae (P=0.001) and a positive correlation between the number of MCs and the degree of inflammation (P<0.001). The MC count did not correlate with the collagen fibers or VEGF positive cells (P>0.05). CONCLUSIONS: The involvement of MCs in the pathogenesis of the oral inflammatory lesions is suggested. However, there was no positive correlation with these cells and collagen fibers or angiogenesis in the lesions studied.
Asunto(s)
Colágeno/análisis , Mastocitos/fisiología , Enfermedades de la Boca/patología , Factor A de Crecimiento Endotelial Vascular/análisis , Adulto , Recuento de Células , Estudios Transversales , Células Endoteliales/química , Células Endoteliales/patología , Matriz Extracelular/química , Matriz Extracelular/patología , Femenino , Fibrosis , Gingivitis/metabolismo , Gingivitis/patología , Granuloma Piogénico/metabolismo , Granuloma Piogénico/patología , Humanos , Hiperplasia , Masculino , Enfermedades de la Boca/metabolismo , Mucosa Bucal/metabolismo , Mucosa Bucal/patología , Neovascularización Patológica/metabolismo , Granuloma Periapical/metabolismo , Granuloma Periapical/patología , Quiste Radicular/metabolismo , Quiste Radicular/patología , Coloración y Etiquetado , Estomatitis/metabolismo , Estomatitis/patologíaRESUMEN
PURPOSE: To provide a critical analysis of a series of periocular lobular capillary hemangiomas in adults, outlining characteristic clinical and histopathologic patterns in comparison with those of other vascular tumors of adults and children. DESIGN: Retrospective observational case series. METHODS: Review of clinical data, hematoxylin-eosin-stained sections, and immunohistochemical studies of smooth muscle actin (SMA), D2-40, CD34, and glucose transporter 1 (GLUT-1). RESULTS: The 7 female and 4 male patients were diagnosed with periocular lobular capillary hemangioma at a median age of 39 years (range, 17-82 years). The tumors were small (3-14 mm, median size 6 mm) and well circumscribed, arose over the course of weeks to months, and developed most commonly in the canthal region, followed by the upper eyelid skin. The tumors were all composed microscopically of repeating units of various sizes (lobules) consisting of CD34-postive, GLUT-1-negative endothelial cells and SMA-positive pericytes arranged in macro- or microlobules. Some foci also exhibited ectatic vessels or diffuse, nonlobular capillary proliferations. Excision was curative without recurrence. CONCLUSION: Although capillary hemangiomas are more common in children, lobular capillary hemangiomas can also arise in the periocular region of adults. Some histopathologic features of these lesions are shared with those of infantile hemangioma and tufted angioma of children, but features of the clinical presentation and the results of immunohistochemical staining patterns are distinctive.
Asunto(s)
Enfermedades de los Párpados/patología , Granuloma Piogénico/patología , Enfermedades de la Piel/patología , Actinas/metabolismo , Adolescente , Adulto , Anciano de 80 o más Años , Anticuerpos Monoclonales de Origen Murino/metabolismo , Antígenos CD34/metabolismo , Biomarcadores/metabolismo , Enfermedades de los Párpados/metabolismo , Femenino , Transportador de Glucosa de Tipo 1/metabolismo , Granuloma Piogénico/metabolismo , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Enfermedades de la Piel/metabolismo , Adulto JovenRESUMEN
Reactive proliferations of the gingiva comprise lesions such as pyogenic granuloma (PG), inflammatory fibroepithelial hyperplasia (IFH), peripheral ossifying fibroma (POF), and peripheral giant cell lesion. Osteopontin (OPN) has a dual role, it promotes mineralization when it is bound to solid substrate, and on the other hand, it inhibits mineralization when it is seen in association with solution. Objectives The study aimed to evaluate the expression of osteopontin in normal gingival tissue and different types of focal reactive proliferations of gingival tissue, and its role in the development of calcification within it. Material and Methods The presence and distribution of osteopontin was assessed using immunohistochemistry in five cases of normal gingival tissue and 30 cases of focal reactive proliferations of gingiva. Results There was no expression of osteopontin in normal subjects. Few cases of pyogenic granuloma, inflammatory fibroepithelial hyperplasia, and all the cases of peripheral ossifying fibroma showed positivity for osteopontin in the inflammatory cells, stromal cells, extracellular matrix, and in the calcifications. Conclusion The expression of osteopontin in all the cases of peripheral ossifying fibroma speculates that the majority of the cases of peripheral ossifying fibroma originate from the periodontal ligament cells. The treatment modalities for peripheral ossifying fibroma should differ from other focal reactive proliferations of gingiva.
Asunto(s)
Encía/metabolismo , Enfermedades de las Encías/metabolismo , Osteopontina/metabolismo , Neoplasias Óseas/metabolismo , Estudios de Casos y Controles , Fibroma Osificante/metabolismo , Tumores de Células Gigantes/metabolismo , Granuloma Piogénico/metabolismo , Humanos , Hiperplasia/metabolismo , Inmunohistoquímica , Valores de ReferenciaAsunto(s)
Regulación Neoplásica de la Expresión Génica , Granuloma Piogénico/genética , Mutación , Neoplasias Vasculares/genética , Proteínas ras/genética , Adolescente , Proliferación Celular , Niño , Preescolar , Femenino , Granuloma Piogénico/metabolismo , Humanos , Lactante , Recién Nacido , Masculino , Neoplasias Vasculares/metabolismo , Proteínas ras/metabolismoRESUMEN
Reactive proliferations of the gingiva comprise lesions such as pyogenic granuloma (PG), inflammatory fibroepithelial hyperplasia (IFH), peripheral ossifying fibroma (POF), and peripheral giant cell lesion. Osteopontin (OPN) has a dual role, it promotes mineralization when it is bound to solid substrate, and on the other hand, it inhibits mineralization when it is seen in association with solution. Objectives The study aimed to evaluate the expression of osteopontin in normal gingival tissue and different types of focal reactive proliferations of gingival tissue, and its role in the development of calcification within it. Material and Methods The presence and distribution of osteopontin was assessed using immunohistochemistry in five cases of normal gingival tissue and 30 cases of focal reactive proliferations of gingiva. Results There was no expression of osteopontin in normal subjects. Few cases of pyogenic granuloma, inflammatory fibroepithelial hyperplasia, and all the cases of peripheral ossifying fibroma showed positivity for osteopontin in the inflammatory cells, stromal cells, extracellular matrix, and in the calcifications. Conclusion The expression of osteopontin in all the cases of peripheral ossifying fibroma speculates that the majority of the cases of peripheral ossifying fibroma originate from the periodontal ligament cells. The treatment modalities for peripheral ossifying fibroma should differ from other focal reactive proliferations of gingiva. .
Asunto(s)
Humanos , Encía/metabolismo , Enfermedades de las Encías/metabolismo , Osteopontina/metabolismo , Neoplasias Óseas/metabolismo , Estudios de Casos y Controles , Fibroma Osificante/metabolismo , Tumores de Células Gigantes/metabolismo , Granuloma Piogénico/metabolismo , Hiperplasia/metabolismo , Inmunohistoquímica , Valores de ReferenciaAsunto(s)
Colon/química , Pólipos del Colon/diagnóstico , Granuloma Piogénico/diagnóstico , Mucosa Intestinal/química , Melaninas/análisis , Adulto , Biomarcadores/análisis , Biopsia , Colon/patología , Colon/cirugía , Pólipos del Colon/metabolismo , Pólipos del Colon/patología , Pólipos del Colon/cirugía , Colonoscopía , Femenino , Granuloma Piogénico/metabolismo , Granuloma Piogénico/patología , Granuloma Piogénico/cirugía , Humanos , Mucosa Intestinal/patología , Mucosa Intestinal/cirugía , Valor Predictivo de las Pruebas , Factores de Tiempo , Resultado del TratamientoRESUMEN
Angiosarcomas are rare malignant vascular tumours. Angiosarcoma expression of vascular endothelial growth factor (VEGF) has previously been reported, but angiosarcoma expression of other angiogenic growth factors has not been systematically studied. Non-VEGF angiogenic growth factors are a potential mechanism of resistance to VEGF-targeted therapy, but they also represent potential therapeutic targets. Immunohistochemistry analysis evaluated the expression of 13 angiogenic growth factors and receptors in 27 separate benign and malignant archived human vascular tumour samples. The expression of 55 angiogenesis-related proteins was subsequently profiled in five fresh human angiosarcoma tumour samples using antibody arrays. Angiosarcomas expressed a variety of angiogenic growth factors. Significantly higher levels of Notch1 were detected compared with benign haemangiomas (p=0.033), but lower levels of basic fibroblast growth factor (bFGF) compared to benign haemangiomas (p=0.07) and inflammatory vascular lesions (p=0.009). Vascular tumour expression of FGF receptor (FGFR)-1 correlated with angiopoietin (Ang)-2, Tie2, hepatocyte growth factor (HGF) and Notch1 expression (p=0.001, p=0.001, p<0.001 and p<0.001 respectively). Notch1 also correlated with Tie2 expression (p=0.004). In conclusion, angiosarcomas express multiple angiogenic growth factors. Treatments could be targeted at individual angiogenic growth factors. However, our findings provide a rationale for combination therapy, or for treatments that target common downstream signalling intermediaries, such as Akt, mTOR or ERK.